Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy

• Published in: BMC research notes 2020-03, Vol.13 (1), p.155-155, Article 155
• Main Authors: Prado, Marcelle SanJuan Ganem, de Jesus, Mirthz Lemos, de Goes, Thaline Cunha, Mendonça, Lucilla Silva Oliveira, Kaneto, Carla Martins
• Format: Article
• Language: English
• Subjects: Biological markers; Biomarker; Biomarkers; Biomarkers - blood; Cellular proteins; Circulating MicroRNA - blood; Circulating MicroRNA - genetics; Circulating microRNAs; Diabetes; Diabetes mellitus; Diabetes therapy; Diabetic Retinopathy; Diabetic Retinopathy - blood; Diabetic Retinopathy - genetics; Disease; Diseases; Down-Regulation; EDTA; Female; Gene expression; Gene Expression Profiling; Gene Expression Regulation - genetics; Gene Ontology; Genes; Genetic aspects; Health aspects; Humans; Male; Metabolism; MicroRNA; MicroRNAs; MicroRNAs - blood; Middle Aged; Novels; Pathogenesis; Real-Time Polymerase Chain Reaction; Research Note; Retinopathy; Signal Transduction - genetics; Software; Studies
• ISSN: 1756-0500; 1756-0500
• DOI: 10.1186/s13104-020-05001-9

To evaluate the expression of a set of miRNAs to identify differentially expressed miRNAs that might be considered reliable biomarkers on Diabetic Retinopathy (DR) blood samples. Expression levels of MiR-320a, MiR-342-3p, MiR-155, MiR-99a, MiR-29a and MiR-27b were analyzed in 60 healthy controls, 48 Diabetes Melitus (DM) without DR patients and 62 DR patients by qRT-PCR. MiR-320a was shown to be downregulated in the plasma of DR patients compared with DM patients without DR and healthy subjects. Target genes were predicted using miRWalk3.0, miR targeting data and target gene interaction data were imported to Cytoscape to visualize and merge networks and top ranked predicted genes were run through Ontology Genes to perform enrichment analysis on gene sets and classification system to identify biological processes and reactome pathways associated with DR. Highly scored target genes of miR-320a were categorized for various biological processes, including negative regulation of cell aging, negative regulation of cellular protein metabolic process and regulation of cellular response to stress that are critical to the development of DR. Our findings suggest that MiR-320a may have a role in the pathogenesis of DR and may represent novel biomarkers for this disease.